Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Trading Down 2.4% – Here’s What Happened

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) shares were down 2.4% on Thursday . The company traded as low as $38.28 and last traded at $38.71. Approximately 818 shares traded hands during trading, a decline of 85% from the average daily volume of 5,407 shares. The stock had previously closed at $39.67.

Innovator IBD Breakout Opportunities ETF Stock Performance

The stock has a market cap of $13.26 million, a price-to-earnings ratio of 28.69 and a beta of 1.08. The business’s fifty day simple moving average is $39.19 and its 200 day simple moving average is $38.27.

Innovator IBD Breakout Opportunities ETF Dividend Announcement

The firm also recently announced an annual dividend, which was paid on Friday, January 2nd. Investors of record on Wednesday, December 31st were paid a dividend of $0.1249 per share. The ex-dividend date was Wednesday, December 31st. This represents a yield of 34.0%.

Institutional Investors Weigh In On Innovator IBD Breakout Opportunities ETF

Several hedge funds have recently modified their holdings of BOUT. Susquehanna International Group LLP lifted its stake in Innovator IBD Breakout Opportunities ETF by 42.6% during the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock worth $1,020,000 after purchasing an additional 7,817 shares during the period. Comprehensive Wealth Management LLC raised its stake in Innovator IBD Breakout Opportunities ETF by 122.0% during the fourth quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock worth $850,000 after acquiring an additional 12,859 shares in the last quarter. Finally, Osaic Holdings Inc. lifted its holdings in shares of Innovator IBD Breakout Opportunities ETF by 39.7% during the second quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after acquiring an additional 597 shares during the period.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.